Retinoic acid induces insulin-like growth factor II expression in a neuroblastoma cell line

Cancer Lett. 1993 Jul 30;71(1-3):177-82. doi: 10.1016/0304-3835(93)90113-n.

Abstract

Insulin-like growth factor II (IGF-II) is implicated in the development of the vertebrate neural circuitry, and increases neurite growth in vitro and in vivo. We examined the relationship of IGF-II expression to the in vitro differentiation induced by retinoic acid (RA). We find that RA stimulates an increase in IGF-II messenger RNA (mRNA) in the SK-N-SH (SH) neuroblastoma cell line. An increase of IGF-II mRNA is detected within 12 h of treatment and precedes morphological differentiation. A RA dose response test indicates that an increase in IGF-II mRNA occurs within 2 days in SH cells treated with doses of RA from 1 x 10(-8) to 1 x 10(-5) M. We suggest that IGF-II expression may be regulated either directly or indirectly by RA in vitro and may lead to neuroblastoma differentiation.

MeSH terms

  • Cell Differentiation
  • Cell Line / drug effects
  • Cell Line / metabolism
  • Dose-Response Relationship, Drug
  • Gene Expression Regulation / drug effects
  • Humans
  • Insulin-Like Growth Factor II / genetics
  • Insulin-Like Growth Factor II / metabolism*
  • Neurites / drug effects
  • Neuroblastoma / drug therapy
  • RNA, Messenger / analysis
  • Time Factors
  • Tretinoin / pharmacology*

Substances

  • RNA, Messenger
  • Tretinoin
  • Insulin-Like Growth Factor II